Company release, 15 June 2022 at 09:00 a.m. (EEST)
During financial year 1 July 2022 – 30 June 2023, Nightingale Health Plc will release its financial reports as follows:
- Financial statements release for 1 July 2021 – 30 June 2022 on Thursday, 29 September 2022
- Half-year financial report for 1 July – 31 December 2022 on Thursday, 2 March 2023
Nightingale Health’s Annual Report 2021 – 2022 will be published during week 43/2022.
Nightingale Health’s Annual General Meeting 2022 will be held on Thursday, 17 November 2022. The Board of Directors will convene the meeting at a later date.
More information on the events of the financial year will be available on the company’s investor pages at https://nightingalehealth.com/investors.
For further information, please contact:
Teemu Suna, CEO
Oaklins Merasco Ltd. tel. +358 9 6129 670
About Nightingale Health
Nightingale Health is The Preventative Health Company. Staying healthy is one of the top priorities in human life. Our health has a profound impact on our quality of life, and it’s also strongly connected to the lives of those close to us. Nightingale Health enables prevention by combining the power of our in-house developed, advanced blood analysis technology with unprecedented access to global health repositories and world-leading medical research. With this combination, we go beyond the traditional healthcare and wellbeing tools: We provide the scientific connection to multiple health and disease outcomes and the ability to predict future healthy years.